Saturday 19 January, 2019
Edition: English (US)
MMJ Observer
Tag Archives: Amicus Therapeutics Inc. (NASDAQ:FOLD)

Amicus Therapeutics, Inc. (NASDAQ:FOLD) initiated the phase 1/2 clinical trial to find the effectiveness and safety of AAV9-CLN3 (adeno associated virus serotype 9 AAV9-CLN3) in children suffering from CLN3 Batten Disease. The company has not...

By Rebecca Harrison on Jan 4th, 2019